No Data
No Data
Cancer Cachexia Pipeline Insights Report, 2024 Featuring Emerging Drugs Macimorelin (AEterna Zentaris) and PF-06946860 (Pfizer)
Aeterna and Ceapro Brief: Aeterna Zentaris Announcing Details Regarding Transaction With Ceapro
08:01 AM EDT, 05/17/2024 (MT Newswires) -- Aeterna and Ceapro Brief: Aeterna Zentaris Announcing Details Regarding Transaction with Ceapro
Aeterna Zentaris Announces Details Regarding Transaction With Ceapro
The Toronto Stock Exchange and Nasdaq have determined that the Common Shares will trade on a due bill basis from the opening of markets on May 29, 2024 to the Payment Date (i.e., May 31, 2024), inclusive.
Aeterna Zentaris Reports Q1 Financial Dip
AEterna Zentaris | 6-K: Report of foreign private issuer (related to financial reporting)
Aeterna Zentaris: Q1 Results and Upcoming Merger